Healthcare workers have a high risk of exposure to the coronavirus disease-2019 (COVID-19)
1
and we lost many colleagues during this pandemic worldwide. As healthcare workers
are high risk, they are one of the main groups for vaccine trials and population studies
which its importance increased during pandemic due to priorisation of healthcare workers
for COVID-19 vaccine.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of InfectionAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers.J Infect. 2021; 82: 399-406https://doi.org/10.1016/j.jinf.2021.01.020
- Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.Lancet. 2021; (published online)https://doi.org/10.1016/S0140-6736(21)00947-8
- Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.Lancet Infect Dis. 2021; 21: 181-192https://doi.org/10.1016/S1473-3099(20)30843-4
Bueno S.M., Katia Abarca K., González P.A., Galvez N.M.S., Soto J.A., Duarte L.F. et al. Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial. https://www.medrxiv.org/content/10.1101/2021.03.31.21254494v1; doi: https://doi.org/10.1101/2021.03.31.21254494
https://covid19.saglik.gov.tr/TR-66935/genel-koronavirus-tablosu.html#. (accessed May 17, 2021).
https://siyahkurdele.com/(accessed May 17, 2021).
- Emergence of a new SARS-CoV-2 variant in the UK.J Infect. 2021; 82: e27-e28https://doi.org/10.1016/j.jinf.2020.12.024
- Mortality risk in patients infected with SARS-CoV-2 of the lineage B.1.1.7 in the UK.J Infect. 2021; (published online May 13)https://doi.org/10.1016/j.jinf.2021.05.008
Article info
Publication history
Published online: June 08, 2021
Accepted:
June 5,
2021
Identification
Copyright
© 2021 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
